Critical Lower Limb Ischemia Should Be Taken into Account in TAVR

Courtesy of Dr. Carlos Fava.

Peripheral vascular diseases (PVD) present the same risk factors as aortic stenosis. In consequence, these disorders usually coexist.

Debemos tener en cuenta a la isquemia crítica de MM II en el TAVI

The frequency and impact of their various stages on patients undergoing TAVR is yet to be thoroughly assessed.


Read also: Peripheral Vascular Disease Is Associated to More Events in TAVR”.


This study analyzed 32,044 patients who underwent TAVR between 2007 and 2013. Among them, 3375 (10.5%) experienced PVD. Additionally, within this subgroup, 2721 patients (80.6%) presented intermittent claudication (IC) and 654 (19.4%) experienced critical ischemia (CI).

 

The PVD group presented more comorbidities and a higher risk score.

 

Transfemoral access was used in 68.9% of all cases and transapical access was used in the remaining 31.1%.


Read also: Latest articles about peripheral vascular diseases”.


The in-hospital mortality among patients without PVD, IC, and CI was 6.1%, 8.4%, and 14.7%, respectively (p < 0.001). The rates of stroke, bleeding, and renal insufficiency were higher among patients with PVD, particularly those in the CI subgroup. In a multivariate analysis, CI was a predictor of in-hospital mortality (odds ratio: 1.96; 95% confidence interval: 1.56-2.47; p < 0.001).

 

The rates of in-hospital stay and need for ventilation were higher among patients in the PVD group with critical ischemia.

 

Conclusion

In patients undergoing TAVR, the presence of PVD is associated with an increased risk of periprocedural complications, while only critical ischemia predicts in-hospital mortality.

 

Editorial Comment

PVD entails more vascular compromise, thus relating to higher risks and worse outcomes, particularly in high-risk patients undergoing TAVR.

 

This study was carried out with first-generation valves, mainly, which may be related to more acute complications for this group. Valves of lower profile and greater group experience will surely set a trend towards decreased complications.

 

That notwithstanding, we shall always remember that PVD is one of our worst enemies.

 

Courtesy of Dr. Carlos Fava.

 

Original title: Prevalence and Impact of Critical Limb Ischaemia on In-Hospital Outcome in Transcatheter Aortic Valve Implantation.

Reference: Nasser M. Malyar, et al. EuroIntervention 2017,13:1282-1288.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

 

More articles by this author

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...